(Press-News.org) On the occasion of its annual general assembly in Singapore on 16 July 2023, the International Institute of Welding presented Sergio Amancio, from the Institute of Materials Science, Joining and Forming at Graz University of Technology (TU Graz), with this year’s Yoshiaki Arata Award in recognition of his scientific achievements. This award, consisting of a medal and a certificate, is considered one of the world’s most important awards for research in welding and additive manufacturing and usually goes to veteran researchers who are recognised for their life’s work. For the first time in its almost 30-year history, the award has been given to a still quite young researcher in the middle of his career – Sergio Amancio.
Making aircraft and cars lighter
The holder of the Professorship for Innovative Materials and Manufacturing Technology in Aviation endowed by the ministry of climate protection (BMK) deals, among other things, with new and energy-efficient solid-state joining processes of lightweight alloys as well as their hybrid structures with polymers or composite materials. In addition, he conducts research into the development of additive manufacturing processes for structural and shape-memory alloys as well as metal-polymer hybrid structures. The most important fields of application for Sergio Amancio’s work include the lightweight construction of future aircraft and cars where the use of rivets or fasteners and thus additional weight can be dispensed due to the welding and joining techniques he has developed. This should reduce fuel consumption and increase maintenance intervals of future airplanes and vehicles.
The difference between welding and joining is that welding involves mixing two identical materials, i.e. metal with metal or polymer with polymer. In contrast, joining involves combining different materials, for example metal with polymer, and there is no mixing because of the physical-chemical differences between the two families of materials.
An award for many companions
In terms of his developments, Sergio Amancio now holds 22 patents, with 15 more pending. For his research and development work in the field of materials science, he has already won the DGM Prize in 2022, one of the most important awards in this field, although he emphasises that the prizes are also an honour for his mentors, colleagues and family.
“The Arata Award, together with the DGM Prize, is the greatest honour for me in my manufacturing engineering career so far,” said Sergio Amancio. “But I didn’t achieve all this alone and there are so many people I want to thank. My parents, my brother and sister, my best friend and wife Gisele and also companions such as Volker Leiser, Stephen Liu, Jorge F. dos Santos, Christof Sommitsch, Franz Haas and all my current and former students, doctoral students and colleagues. I myself have always been very curious, especially when it came to the difficult problem of joining metal with polymer. In our collective hard work, we have tried out, experimented and tested a lot and also achieved a lot. So, this award doesn’t belong to me alone.”
END
Sergio Amancio receives 2023 Yoshiaki Arata Award
The researcher from Graz University of Technology was recognised for his scientific achievements in science and technology of welding and joining with one of the world’s most relevant awards in this field
2023-07-17
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Current evidence identifies health risks of e-cigarette use; long-term research needed
2023-07-17
Statement Highlights:
The number of people who use electronic nicotine delivery systems, typically referred to as e-cigarettes, has grown exponentially, especially among youth and young adults. E-cigarette use more than doubled from 2017 to 2019 among middle and high school students.
Ingredients of e-cigarettes, including nicotine, flavoring agents, sweeteners and propylene glycol and vegetable glycerol, may each independently pose dangerous health risks.
More clinical studies on the long-term impact of e-cigarettes on the heart, blood vessels and lungs are needed, and experts emphasize additional molecular and laboratory research ...
Developing new materials to accelerate the arrival of 'air taxis'
2023-07-17
In order for future mobility, such as urban air mobility (UAM), to become a reality, it must be fuel efficient and reduce carbon emissions, which requires the development of new materials with excellent physical properties and recyclability. Self-reinforced composites (SRCs) are inexpensive, lightweight, and have advantages in terms of disposal and recycling as the reinforcement and the base material are composed of the same material. For this reason, it is attracting attention as a next-generation composite material to replace carbon fiber-reinforced composites used in aircraft.
Korea Institute of Science and Technology (KIST, President ...
New findings suggest historical infanticide in Europe likely more widespread than estimated
2023-07-17
‘Routine’ infanticide of newborns by married parents in early modern Europe was a much more widespread practice than previously thought, a new book posits.
This fresh insight sits at the heart of a new book, Death Control in the West 1500–1800: Sex Ratios at Baptism in Italy, France and England, by Gregory Hanlon and contributors.
The French-trained behavioural historian explains: “In most cases, infanticide was a crime leaving no aggrieved party seeking revenge if it was committed right away. It could be overlooked and forgotten with the passage of time.”
Widespread infanticide
Hanlon, who is Distinguished Research Professor at Dalhousie University in ...
Prescribing psychostimulants for people at risk of overdose
2023-07-17
Growing evidence supports prescribing psychostimulant medications to help reduce use of illegal stimulants such as methamphetamine, authors write in a CMAJ (Canadian Medical Association Journal) commentaryhttps://www.cmaj.ca/lookup/doi/10.1503/cmaj.230266.
Illegal stimulant use is rising, judging by the presence of these drugs in at least half of all opioid deaths in Canada in 2022.
Following evidence from clinical trials in Australia, Europe and the United States, physicians and nurse practitioners in Canada and other countries are increasingly prescribing psychostimulants as harm reduction for stimulant use disorder.
"This emerging ...
THE LANCET ONCOLOGY: Cancer experts call for cancer care to be centred on patients rather than the commercial bottom-line
2023-07-17
Commercial, rather than patient interests, often drive cancer care and research and patients deserve better, argue a group of global oncologists and patient advocates in a Comment published in The Lancet Oncology journal. The authors also establish core guidelines for the development of a new patient-centred movement in cancer care - Common Sense Oncology.
The Comment says there has been a shift over the past few decades from predominantly publicly funded clinical trials designed to answer questions important to patients, to industry-funded trials which aim to achieve ...
Significant rise in ADHD diagnoses in the UK
2023-07-17
Both ADHD diagnoses and prescriptions for ADHD medication have increased significantly over the past two decades, except in children under five, finds a new study by UCL researchers.
The research, published in BJPsych Open, reviewed data from 7 million individuals aged three to 99, from IQVIA Medical Research Data, a UK primary care database, between 2000 and 2018.
Of these individuals, 35,877 had an ADHD diagnosis and 18,518 received prescriptions for ADHD medication from their GP.
Although the number of individuals receiving medication for ADHD is still relatively low, the researchers found ...
New guidelines for diagnosing Alzheimer's
2023-07-16
Today at the International Alzheimer's Congress (AAIC) in Amsterdam, new guidelines for diagnosing Alzheimer's disease developed by clinicians and researchers from around the world were presented. In these criteria, the disease is diagnosed in the clinic through the use of blood biomarkers, just as with other major diseases such as diabetes and cardiovascular disease.
A blood test has been developed for this purpose in recent years that gives very good results, according to recent research. Charlotte Teunissen, professor of neurochemistry at Amsterdam ...
Discovery could lead to more treatments to prevent cancer and infectious diseases
2023-07-16
Researchers have cracked how a particular type of immune cell develops in the body and protects against infection and disease. And the discovery could help in the development of more preventive treatments, according to a new study.
The research, led by Murdoch Children’s Research Institute and Federation University Australia, has uncovered how these specialised white blood cells operate and can produce an immune response.
Associate Professor Dan Pellicci said by understanding the function of these cells, they could be harnessed to help prevent cancer and highly infectious diseases such as ...
Unimolecular reactions of anti-glycolaldehyde oxide and its reactions with one and two water molecules
2023-07-15
Criegee intermediates are produced in the ozonolysis of unsaturated compounds in the atmosphere. These intermediates are especially importanct because they contribute to the formation of OH radical during the night and to formation of secondary organic aerosols. The OH radicals increase the oxidative capacity of the atmosphere, and the aerosols may reflect or absorb sunlight and contribute to cloud formation. Criegee intermediates also lay key roles in conversion of sulfur dioxide into sulfur trioxide, finally resulting in the formation ...
5-aminolevulinic acid might help fight mitochondrial disorders
2023-07-15
Tokyo, Japan – Scientists from Tokyo Metropolitan University have shown that 5-aminolevulinic acid (5-ALA) helps bypass deficiencies in Complex I (CI), the first in a series of protein complexes that transport electrons and help power the mitochondria. They showed that fruit flies missing the analogous protein showed improved health when given a cocktail of drugs including 5-ALA. CI deficiency is responsible for the majority of mitochondrial disorders; the team’s findings might lead to new therapies.
Mitochondrial diseases arise from problems in the mitochondria, a small organelle in cells which produces adenosine triphosphate (ATP), ...
LAST 30 PRESS RELEASES:
Azacitidine–venetoclax combination outperforms standard care in acute myeloid leukemia patients eligible for intensive chemotherapy
Adding epcoritamab to standard second-line therapy improves follicular lymphoma outcomes
New findings support a chemo-free approach for treating Ph+ ALL
Non-covalent btki pirtobrutinib shows promise as frontline therapy for CLL/SLL
University of Cincinnati experts present research at annual hematology event
ASH 2025: Antibody therapy eradicates traces of multiple myeloma in preliminary trial
ASH 2025: AI uncovers how DNA architecture failures trigger blood cancer
ASH 2025: New study shows that patients can safely receive stem cell transplants from mismatched, unrelated donors
Protective regimen allows successful stem cell transplant even without close genetic match between donor and recipient
Continuous and fixed-duration treatments result in similar outcomes for CLL
Measurable residual disease shows strong potential as an early indicator of survival in patients with acute myeloid leukemia
Chemotherapy and radiation are comparable as pre-transplant conditioning for patients with b-acute lymphoblastic leukemia who have no measurable residual disease
Roughly one-third of families with children being treated for leukemia struggle to pay living expenses
Quality improvement project results in increased screening and treatment for iron deficiency in pregnancy
IV iron improves survival, increases hemoglobin in hospitalized patients with iron-deficiency anemia and an acute infection
Black patients with acute myeloid leukemia are younger at diagnosis and experience poorer survival outcomes than White patients
Emergency departments fall short on delivering timely treatment for sickle cell pain
Study shows no clear evidence of harm from hydroxyurea use during pregnancy
Long-term outlook is positive for most after hematopoietic cell transplant for sickle cell disease
Study offers real-world data on commercial implementation of gene therapies for sickle cell disease and beta thalassemia
Early results suggest exa-cel gene therapy works well in children
NTIDE: Disability employment holds steady after data hiatus
Social lives of viruses affect antiviral resistance
Dose of psilocybin, dash of rabies point to treatment for depression
Helping health care providers navigate social, political, and legal barriers to patient care
Barrow Neurological Institute, University of Calgary study urges “major change” to migraine treatment in Emergency Departments
Using smartphones to improve disaster search and rescue
Robust new photocatalyst paves the way for cleaner hydrogen peroxide production and greener chemical manufacturing
Ultrafast material captures toxic PFAS at record speed and capacity
Plant phenolic acids supercharge old antibiotics against multidrug resistant E. coli
[Press-News.org] Sergio Amancio receives 2023 Yoshiaki Arata AwardThe researcher from Graz University of Technology was recognised for his scientific achievements in science and technology of welding and joining with one of the world’s most relevant awards in this field